More articles from Keynote Presentations

• Measuring disease activity and outcomes in clinical studies

  Raashid Luqmani, DM, FRCP (Edin)

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-100-SII-102;
• Inflammation in acute coronary syndromes

  Mark Robbins, MD and Eric J. Topol, MD

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-130-SII-142;
• Sinonasal complications of vasculitic diseases

  Robert S. Lebovics, MD, FACS

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-152-SII-154;
• Pathogenic mechanisms in giant cell arteritis

  Cornelia M. Weyand, MD and Jörg J. Goronzy, MD

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-28-SII-32;
• Conventional treatment and outcome of Wegener’s granulomatosis and microscopic polyangiitis

  David R.W. Jayne, MD

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-110-SII-115;
• Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis

  J. Charles Jennette, MD

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-33-SII-38;
• Infections in primary vasculitides

  J.W. Cohen Tervaert, MD, PhD

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-24-SII-26;
• Diagnostic strategies in vasculitis affecting the central nervous system

  Leonard H. Calabrese, DO

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-105-SII-108;
• Surgical treatment of Takayasu’s disease

  Joseph M. Giordano, MD, FACS

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-146-SII-148;
• New approaches to the management of subglottic stenosis in Wegener’s granulomatosis

  Isaac Eliachar, MD, James Chan, MD and Lee Akst, MD

  • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-149-SII-151;

Previous

Next

• 1
• 2
• 3